Evidence map›Paper›PMID 16807804›Full record

ReviewJournal of mammary gland biology and neoplasia2005

Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression.

Sanford H Barsky, Nina J Karlin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of mammary gland biology and neoplasia, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 129 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Microenvironment in DCIS and Its Role in Disease Progression.Advances in experimental medicine and biology · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. 3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages.International journal of molecular sciences · 2021
    Review
  14. Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ.Journal of mammary gland biology and neoplasia · 2019
    Review
  19. Review
  20. Myoepithelial crowd control of cancer cells.The Journal of cell biology · 2018
    Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sanford H BarskyDepartment of Pathology, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA. sanford.barsky@osumc.edu
Nina J Karlin
Olive View-UCLA Medical Center · USThe Ohio State University · US

Funding

THE DESMOPLASTIC RESPONSE TO TUMOR INVASIONR01CA040225 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BARSKY, SANFORD HOWARD · 1985 to 1994
–
NOVEL MYOEPITHELIAL CELL LINE TO SUPPORT 1 BREAST CR03CA071195 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BARSKY, SANFORD HOWARD · 1996 to 1997
–
NCI NIH HHS CA01351NCI NIH HHS CA40225NCI NIH HHS CA71195
6 · The paper itself

Abstract

Host cellular paracrine regulation of tumor progression is an important determinant of tumor biology but one cell that has been ignored in this regulation is the myoepithelial cell. Myoepithelial cells surround normal ducts and precancerous lesions, especially of the breast and form a natural border separating proliferating epithelial cells from proliferating endothelial cells (angiogenesis). Myoepithelial cells may thus negatively regulate tumor invasion and metastasis. Whereas epithelial cells are susceptible targets for transforming events, myoepithelial cells are resistant. Therefore, it can be said that myoepithelial cells function as both autocrine as well as paracrine tumor suppressors. Our laboratory has found that myoepithelial cells secrete a number of suppressor molecules including high amounts of diverse proteinase inhibitors and angiogenic inhibitors but low amounts of proteinases and angiogenic factors compared to common malignant cell lines. This observation has been made in vitro, in mice, and in humans and suggests that myoepithelial cells exert pleiotropic suppressive effects on tumor progression. The gene expression profile of myoepithelial cells may explain the pronounced anti-invasive and anti-angiogenic effects of myoepithelial cells on carcinoma cells and may also account for the reduced malignancy of myoepithelial tumors, which are devoid of appreciable angiogenesis and invasive behavior.

Indexed as

Autocrine CommunicationParacrine CommunicationAngiogenesis InhibitorsAnimalsAntineoplastic Agents, HormonalBreastBreast NeoplasmsCarcinoma, Ductal, BreastDisease ProgressionEpithelial CellsFemaleGene Expression Regulation, NeoplasticGenes, Tumor SuppressorHumansMaleMiceAngiogenesis InhibitorsAntineoplastic Agents, Hormonal

Identifiers

PMID16807804
OpenAlexW2015847779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.